Harrow Health, Inc. and U.S. Bank Trust Company, National Association, as Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of December 20, 2022 to the Indenture dated as of April 20, 2021 11.875% Senior Notes due 2027Supplemental Indenture • December 20th, 2022 • Harrow Health, Inc. • Pharmaceutical preparations
SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of December 20, 2022, between Harrow Health, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”).
